Rusagro H1 2026: Revenue +9.1% but EBITDA -28.6% and Net Profit -98.8% as Margins Collapse
Rusagro reported H1 2026 revenue of RUB 183.0 bn (+9.1% y/y), but profitability deteriorated sharply: EBITDA fell 28.6% y/y to RUB 13.8 bn and net profit collapsed 98.8% y/y to RUB 55.9 m. Q2 2026 alone showed revenue of RUB 91.5 bn, EBITDA of RUB 6.9 bn and net profit of RUB 27.9 m. The revenue growth decelerated from +13.6% in H2 2025 to +9.1% in H1 2026, while the EBITDA decline moderated from -24.2% in H2 2025 to -28.6% in H1 2026 — still deeply negative. The story is one of margin compression overwhelming top-line growth.
H1 2026 vs H1 2025: y/y growth
Margin collapse drives the miss
The divergence between revenue and profit is stark. H1 2026 EBITDA margin fell to 7.5% (13,781.666 / 183,039.298) from 11.5% in H1 2025 (19,314.889 / 167,774.391), a loss of roughly 4 percentage points. Net margin collapsed to 0.03% from 2.9% a year earlier. Q2 2026 was similarly weak: EBITDA margin of 7.5% (6,890.666 / 91,519.298) and net margin of 0.03% (27.939 / 91,519.298). The company is growing volumes/revenue but at sharply lower profitability — likely reflecting cost inflation, weaker pricing, or a mix shift toward lower-margin segments. No segment-level breakdown was provided in the facts, so we cannot attribute the decline to specific business lines.
Key figures (RUB m)
| Metric | H1 2025 | H1 2026 | Change |
|---|---|---|---|
| Revenue | 167,774.391 | 183,039.298 | +9.1% |
| EBITDA | 19,314.889 | 13,781.666 | -28.6% |
| Net Profit | 4,831.327 | 55.878 | -98.8% |
| EBITDA margin | 11.5% | 7.5% | -4.0 pp |
| Net margin | 2.9% | 0.03% | -2.9 pp |
Outlook
The key question for H2 2026 is whether the margin trough has been reached. The H1 2026 EBITDA decline of -28.6% is worse than H2 2025's -24.2%, indicating no stabilization yet. Revenue growth, while positive at +9.1%, is decelerating from +13.6% in H2 2025. With net profit near zero, the company has little buffer against further cost pressure. Investors should watch for any management commentary on cost inflation, pricing, and segment mix — none of which was provided in the facts. The balance sheet remains leveraged, with net debt rising over the past 12 months, limiting flexibility.
Open the company's financial profile RAGR →
See also: market overview · valuation map · stock screeners